Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
(221174) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
topiramate compared to phenobarbital result better effect on, both partial, generalized <ref>[http://www.europeanreview.org/wp/wp-content/uploads/993-997.pdf Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital]</ref> | topiramate compared to [[phenobarbitone|phenobarbital]] result better effect on, both partial, generalized <ref>[http://www.europeanreview.org/wp/wp-content/uploads/993-997.pdf Comparison of impact on seizure frequency and epileptiform discharges of children with epilepsy from topiramate and phenobarbital]</ref> | ||
Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | Qudexy<sup>TM</sup> is an extended release form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | ||
<gallery> | <gallery> | ||
Revision as of 19:25, 25 November 2016
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Phentermine and topiramate for the management of obesity: a review
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy